| Literature DB >> 12499047 |
József Németh1, Zsuzsanna Helyes, Márta Thán, Balázs Jakab, Erika Pintér, János Szolcsányi.
Abstract
Most actions of anandamide (AEA) are mediated by the cannabinoid 1 (CB(1)) receptor activation, but on sensory neurones it is also an agonist on the vanilloid subtype 1 receptor (VR(1)). The aim of the present study was to analyse the effect of AEA (10(-6)-10(-4) M) on inhibitory CB(1) and excitatory VR(1) receptors by measuring sensory neuropeptide release such as somatostatin, substance P and calcitonin gene-related peptide, from isolated rat tracheae. AEA (10(-6) M) vas without significant effect, 10(-5) M inhibited neuropeptide release, which was abolished by the G protein-coupled receptor blocker pertussis toxin (100 ng/ml) and the CB(1) receptor antagonist SR141716A (5x10(-7) M). High concentrations of AEA (5x10(-5) M, 10(-4) M) increased the release of the peptides and this inhibition was prevented by the competitive VR(1) antagonist capsazepine (10(-5) M). These results indicate a dual, concentration-dependent action of AEA on CB(1) receptors and VR(1) on peripheral sensory nerve terminals. Copyright 2002 Elsevier Science Ireland Ltd.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12499047 DOI: 10.1016/s0304-3940(02)01221-1
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046